{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:35:33Z","timestamp":1793500533501,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12581-7","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:14:29Z","timestamp":1768533269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Azathioprine for remission maintenance in anti-interferon-\u03b3 autoantibody-associated immunodeficiency syndrome- a retrospective single-center cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Wannada","family":"Laisuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prapaporn","family":"Pisitkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pintip","family":"Ngamjanyaporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supa","family":"Oncham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanatpon","family":"Aonaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prawat","family":"Chantharit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Porpon","family":"Rotjanapan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"12581_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cid\/ciz786","volume":"71","author":"GH Hong","year":"2020","unstructured":"Hong GH, Ortega-Villa AM, Hunsberger S, et al. Natural history and evolution of anti-interferon-gamma autoantibody-associated immunodeficiency syndrome in Thailand and the united States. Clin Infect Dis. 2020;71:53\u201362.","journal-title":"Clin Infect Dis"},{"key":"12581_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.diagmicrobio.2017.05.011","volume":"88","author":"I Hase","year":"2017","unstructured":"Hase I, Morimoto K, Sakagami T, Ishii Y, van Ingen J. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review. Diagn Microbiol Infect Dis. 2017;88:308\u201315.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"12581_CR3","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1111160","volume":"367","author":"SK Browne","year":"2012","unstructured":"Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012;367:725\u201334.","journal-title":"N Engl J Med"},{"key":"12581_CR4","doi-asserted-by":"publisher","first-page":"e3927","DOI":"10.1097\/MD.0000000000003927","volume":"95","author":"CY Chi","year":"2016","unstructured":"Chi CY, Lin CH, Ho MW, et al. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-gamma autoantibodies and disseminated nontuberculous mycobacterial infections. Med (Baltim). 2016;95:e3927.","journal-title":"Med (Baltim)"},{"key":"12581_CR5","doi-asserted-by":"publisher","first-page":"ofaa035","DOI":"10.1093\/ofid\/ofaa035","volume":"7","author":"W Laisuan","year":"2020","unstructured":"Laisuan W, Pisitkun P, Ngamjanyaporn P, Suangtamai T, Rotjanapan P. Prospective pilot study of cyclophosphamide as an adjunct treatment in patients with Adult-Onset immunodeficiency associated with Anti-interferon-gamma autoantibodies. Open Forum Infect Dis. 2020;7:ofaa035.","journal-title":"Open Forum Infect Dis"},{"key":"12581_CR6","doi-asserted-by":"crossref","unstructured":"Leurmarnkul W, Meetam P. Properties testing of the retranslated SF-3 6 (Thai version). Thai J Pharm Sci. 2005;29(1\u20132):69\u201388.","DOI":"10.56808\/3027-7922.2230"},{"key":"12581_CR7","doi-asserted-by":"publisher","first-page":"14346","DOI":"10.1038\/s41598-023-41340-w","volume":"13","author":"J Temsangsukmanee","year":"2023","unstructured":"Temsangsukmanee J, Laisuan W, Thadanipon K, et al. Health related quality of life in anti interferon gamma autoantibody associated immunodeficiency syndrome measured with Eq.\u00a05D5L and SF36. Sci Rep. 2023;13:14346.","journal-title":"Sci Rep"},{"key":"12581_CR8","first-page":"1670","volume":"55","author":"DJ Warren","year":"1995","unstructured":"Warren DJ, Andersen A, Slordal L. Quantitation of 6-thioguanine residues in peripheral blood leukocyte DNA obtained from patients receiving 6-mercaptopurine-based maintenance therapy. Cancer Res. 1995;55:1670\u20134.","journal-title":"Cancer Res"},{"key":"12581_CR9","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1136\/ard-2022-222486","volume":"81","author":"Q Fu","year":"2022","unstructured":"Fu Q, Wu C, Dai M, et al. Leflunomide versus azathioprine for maintenance therapy of lupus nephritis: a prospective, multicentre, randomised trial and long-term follow-up. Ann Rheum Dis. 2022;81:1549\u201355.","journal-title":"Ann Rheum Dis"},{"key":"12581_CR10","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1056\/NEJMoa1014460","volume":"365","author":"MA Dooley","year":"2011","unstructured":"Dooley MA, Jayne D, Ginzler EM, et al. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med. 2011;365:1886\u201395.","journal-title":"N Engl J Med"},{"key":"12581_CR11","doi-asserted-by":"publisher","first-page":"e1003668","DOI":"10.1371\/journal.pmed.1003668","volume":"18","author":"P Ruggenenti","year":"2021","unstructured":"Ruggenenti P, Cravedi P, Gotti E, et al. Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial. PLoS Med. 2021;18:e1003668.","journal-title":"PLoS Med"},{"key":"12581_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jaad.2014.08.048","volume":"72","author":"NR Fuggle","year":"2015","unstructured":"Fuggle NR, Bragoli W, Mahto A, Glover M, Martinez AE, Kinsler VA. The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring. J Am Acad Dermatol. 2015;72:108\u201314.","journal-title":"J Am Acad Dermatol"},{"key":"12581_CR13","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/j.1365-2133.2004.06323.x","volume":"151","author":"AV Anstey","year":"2004","unstructured":"Anstey AV, Wakelin S, Reynolds NJ, British Association of Dermatologists, Therapy G, Audit S. Guidelines for prescribing azathioprine in dermatology. Br J Dermatol. 2004;151:1123\u201332.","journal-title":"Br J Dermatol"},{"key":"12581_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/labmed\/lmab039","volume":"53","author":"R Khositnithikul","year":"2022","unstructured":"Khositnithikul R, Laisuan W, Setthaudom C, et al. Application of quantiferon ELISA for detection of Interferon-Gamma autoantibodies in Adult-Onset immunodeficiency syndrome. Lab Med. 2022;53:12\u20137.","journal-title":"Lab Med"},{"key":"12581_CR15","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1182\/blood-2011-12-395707","volume":"119","author":"SK Browne","year":"2012","unstructured":"Browne SK, Zaman R, Sampaio EP, et al. Anti-CD20 (rituximab) therapy for anti-IFN-gamma autoantibody-associated nontuberculous mycobacterial infection. Blood. 2012;119:3933\u20139.","journal-title":"Blood"},{"key":"12581_CR16","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/cid\/cit809","volume":"58","author":"CA Czaja","year":"2014","unstructured":"Czaja CA, Merkel PA, Chan ED, et al. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-gamma autoantibody. Clin Infect Dis. 2014;58:e115\u20138.","journal-title":"Clin Infect Dis"},{"key":"12581_CR17","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1007\/s10875-023-01537-0","volume":"43","author":"B Zhang","year":"2023","unstructured":"Zhang B, Fan J, Huang C, et al. Characteristics and outcomes of Anti-interferon gamma Antibody-Associated adult onset immunodeficiency. J Clin Immunol. 2023;43:1660\u201370.","journal-title":"J Clin Immunol"},{"key":"12581_CR18","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1038\/s41598-020-65933-x","volume":"10","author":"A Nithichanon","year":"2020","unstructured":"Nithichanon A, Chetchotisakd P, Matsumura T, et al. Diagnosis of NTM active infection in lymphadenopathy patients with anti-interferon-gamma auto-antibody using inhibitory ELISA vs. indirect ELISA. Sci Rep. 2020;10:8968.","journal-title":"Sci Rep"},{"key":"12581_CR19","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1086\/380453","volume":"38","author":"R Doffinger","year":"2004","unstructured":"Doffinger R, Helbert MR, Barcenas-Morales G, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis. 2004;38:e10\u20134.","journal-title":"Clin Infect Dis"},{"key":"12581_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00535-021-01817-9","volume":"56","author":"Y Masaki","year":"2021","unstructured":"Masaki Y, Nakase H, Tsuji Y, et al. The clinical efficacy of azathioprine as maintenance treatment for autoimmune pancreatitis: a systematic review and meta-analysis. J Gastroenterol. 2021;56:869\u201380.","journal-title":"J Gastroenterol"},{"key":"12581_CR21","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1177\/0961203318792352","volume":"27","author":"SC Yang","year":"2018","unstructured":"Yang SC, Lai YY, Huang MC, Tsai CS, Wang JL. Corticosteroid dose and the risk of opportunistic infection in a National systemic lupus erythematosus cohort. Lupus. 2018;27:1819\u201327.","journal-title":"Lupus"},{"key":"12581_CR22","unstructured":"Angkasekvinai N. Treatment of anti-interferon-gamma autoantibody associated acquired immunodeficiency syndrome with bortezomib: pilot study. HSRI Knowl Bank 2020. https:\/\/kb.hsri.or.th\/dspace\/handle\/11228\/5203"},{"key":"12581_CR23","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1038\/ctg.2017.17","volume":"8","author":"N de Pretis","year":"2017","unstructured":"de Pretis N, Amodio A, Bernardoni L, et al. Azathioprine maintenance therapy to prevent relapses in autoimmune pancreatitis. Clin Transl Gastroenterol. 2017;8:e90.","journal-title":"Clin Transl Gastroenterol"},{"key":"12581_CR24","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1177\/1535370220981579","volume":"246","author":"K Chawansuntati","year":"2021","unstructured":"Chawansuntati K, Rattanathammethee K, Wipasa J, Minireview. Insights into anti-interferon-gamma autoantibodies. Exp Biol Med (Maywood). 2021;246:790\u20135.","journal-title":"Exp Biol Med (Maywood)"},{"key":"12581_CR25","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","volume":"362","author":"JF Colombel","year":"2010","unstructured":"Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for crohn\u2019s disease. N Engl J Med. 2010;362:1383\u201395.","journal-title":"N Engl J Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12581-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12581-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12581-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:09:15Z","timestamp":1770772155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12581-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12581"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12581-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the Declaration of Helsinki. Ethical approval (No. MURA2023\/354) was granted by the Research Committee of the Faculty of Medicine Ramathibodi Hospital, Mahidol University, and the requirement for informed consent was waived because of the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"318"}}